A Very Early Rehabilitation Trial

NCT01846247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2014

Last updated 2015-04-15

No results posted yet for this study

Summary

Phase 3, multicenter, international randomized controlled trial of a Very Early Mobilization(VEM) care rehabilitation protocol compared to standard post stroke care (SC). Participants receive either SC and VEM or SC alone in the acute phase of stroke up to a period of 14 days.

Participants are followed up by a blinded assessor at 3 and 12 months post stroke to determine trial outcomes.

Conditions

Interventions

OTHER

Standard Care + VEM

Patient will receive standard stroke unit care with earlier and additional physiotherapy and nursing sessions as per an intervention protocol.

OTHER

Standard care

Sponsors & Collaborators

  • Singhealth Foundation

    collaborator OTHER_GOV
  • Chest, Heart and Stroke Association Scotland

    collaborator OTHER
  • Northern Ireland Chest Heart and Stroke

    collaborator OTHER
  • The Stroke Association - UK

    collaborator UNKNOWN
  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • Neuroscience Trials Australia

    lead OTHER

Principal Investigators

  • Julie Bernhardt, PhD · The Florey Institute of Neuroscience and Mental Health

  • Leonid Churilov, PhD · The Florey Institute of Neuroscience and Mental Health

  • Helen Dewey, MD · Monash University

  • Richard Lindley Dewey, MD · George Institute for Global Health

  • Janice Collier, PhD · The Florey Institute of Neuroscience and Mental Health

  • Amanda Thrift, PhD · Monash University

  • Geoffrey Donnan, MD · The Florey Institute of Neuroscience and Mental Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01846247 on ClinicalTrials.gov